基因組學市場規模、佔有率和成長分析：按產品/服務、最終用戶、研究類型、地區 - 產業預測，2024-2031

2022年基因組學市場規模將為278.1億美元，從2023年的332.5億美元成長到2031年的4113.5億美元，在預測期內（2024-2031年）預計複合年成長率為19.4%。

基因組學是對基因組的研究，重點是研究生物 DNA 的結構、功能、演化和圖譜。該領域對人類生活產生重大影響，並透過基因組學革命推動醫學和生物醫學的快速變革。全球癌症發生率不斷上升，導致政府加大了基因組學計劃的津貼。透過人類基因組的研究使個人化醫療的概念成為可能，它徹底改變了臨床腫瘤學和罕見遺傳疾病的治療。學術界擴大研究遺傳學和認知障礙之間的聯繫，以更好地了解大腦在這些疾病中的作用。由於癌症和癌症治療研究的擴大、對快速且易於理解的臨床診斷的需求不斷增加以及政府機構和生物製藥公司對研發的投資增加，基因組學市場正在經歷快速的收益成長。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價格分析
• 價值鏈分析
• 市場生態系統
• Start-Ups分析
• 專利分析
• 客戶和購買標準分析
• 監管環境
• 創新矩陣
• 重點投資分析
• 關鍵成功因素
• 市場魅力指數
• 競爭程度

基因組市場：依產品/服務分類

• 市場概況
• 耗材/試劑
• 服務
• 設備、系統、軟體

基因組學市場：依技術分類

• 市場概況
• 定序
• PCR
• 流式細胞技術
• 微陣列
• 其他技術

基因組學市場：依應用分類

• 市場概況
• 藥物發現/開發
• 診斷
• 農業/動物研究
• 其他用途

基因組學市場：依研究類型

• 市場概況
• 功能基因體學
• 生物標記發現
• 通路分析
• 表觀基因
• 其他研究類型

基因組學市場：依最終用戶分類

• 市場概況
• 醫院/診所
• 學術/研究機構
• 製藥和生物技術公司
• 其他最終用戶

基因組學市場規模：按地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Illumina, Inc.（US）
• Thermo Fisher Scientific（US）
• Qiagen NV（Netherlands）
• BGI Group（China）
• F. Hoffmann-La Roche AG（Switzerland）
• Danaher Corporation（US）
• Pacific Biosciences of California, Inc.（US）
• Oxford Nanopore Technologies, Ltd.（United Kingdom）
• Agilent Technologies, Inc.（US）
• Eurofins Scientific SE（Luxembourg）
• Bio-Rad Laboratories, Inc.（US）
• Myriad Genetics, Inc.（US）
• Fluidigm Corporation（US）
• PerkinElmer, Inc.（US）
• Twist Bioscience Corporation（US）
• Natera, Inc.（US）
• Veracyte, Inc.（US）
• Personalis, Inc.（US）
• 10x Genomics, Inc.（US）
• Quest Diagnostics（US）

Genomics Market size was valued at USD 27.81 billion in 2022 and is poised to grow from USD 33.25 billion in 2023 to USD 411.35 billion by 2031, growing at a CAGR of 19.4% in the forecast period (2024-2031).

Genomics involves the study of genomes, focusing on the structure, function, evolution, and mapping of an organism's DNA. This field has significantly impacted human life, driving a rapid transformation in medicine and biomedical sciences due to the genomics revolution. The rising global incidence of cancer has prompted increased government support through grants for genomics projects. The concept of personalized medicine, made possible by studying the Human Genome, has revolutionized clinical oncology and the treatment of rare genetic disorders. Academics are increasingly investigating the connection between genetics and cognitive disorders to better understand the brain's role in these conditions. The genomics market is experiencing rapid revenue growth due to the expanding research on cancer and cancer therapies, the growing demand for quick and straightforward clinical diagnoses, and the increased investment in R&D by government organizations and biopharmaceutical companies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Genomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Genomics Market Segmental Analysis

The genomics market is segmented into Product & Service, Technology, Study Type, Application, End Use, and Region. Based on Product and Service, the market is segmented into Consumables and Reagents, Services, Instruments, Systems, and Software. Based on Technology, the market is segmented into Sequencing, PCR, Genomics, Microarrays, Other Technologies. Based on Study Type, the market is segmented into Functional Genomics, Biomarker Discovery, Pathway Analysis, Epigenomics, and Other Study Types. Based on Application, the market is segmented into Drug Discovery and Development, Diagnostics, Agriculture and Animal Research, and Other Applications. Based on End User, the market is segmented into Government and Academic Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Other End Users. Based on Region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

Drivers of the Global Genomics Market

The genomics market is being propelled by the expanding application of Next-Generation Sequencing (NGS) in cancer research. NGS technologies are increasingly utilized for whole-genome sequencing, genome diversity studies, metagenomics, epigenetics, non-coding RNA discovery, protein-binding site identification, and RNA sequencing for gene expression profiling. These diverse applications of NGS are significantly contributing to the growth of the genomics market.

Restraints in the Global Genomics Market

The genomics market is experiencing a growing demand for a skilled genetic workforce. However, a potential limitation is the availability of competent personnel. Additionally, the high cost of genomic equipment and challenges related to data storage for sequenced data from 2023 to 2031 are expected to impact market growth. Integrating genomic approaches and technologies into healthcare systems holds promise for enhancing safety, quality, efficiency, and cost-effectiveness. Nevertheless, achieving these benefits largely depends on the availability of skilled professionals.

Market Trends of the Global Genomics Market

Organizations using the Illumina OmniExpress chip, such as Ancestry.com, will need to transition to the customized Illumina Global Screening Array (GSA) microarray, as the OmniExpress chip will be phased out. This shift will compel these organizations to either adopt the GSA chip, switch to Thermo Fisher Scientific products, or implement next-generation sequencing technology to maintain their operations.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Start-up Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Market Attractive Index
• Degree of Competition

Genomics Market by Product & Service

• Market Overview
• Consumables and Reagents
• Services
• Instruments, Systems, and Software

Genomics Market by Technology

• Market Overview
• Sequencing
• PCR
• Flow Cytometry
• Microarrays
• Other Technologies

Genomics Market by Application

• Market Overview
• Drug Discovery and Development
• Diagnostics
• Agriculture and Animal Research
• Other Applications

Genomics Market by Study Type

• Market Overview
• Functional Genomics
• Biomarker Discovery
• Pathway Analysis
• Epigenomics
• Other Study Types

Genomics Market by End User

• Market Overview
• Hospitals and Clinics
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Other End Users

Genomics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies, Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veracyte, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Personalis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments